CHARLOTTE, North Carolina (GenomeWeb) – T2 Biosystems this week presented data at the Association for Molecular Pathology meeting on the cost savings associated with its T2Candida sepsis panel.

The T2Candida panel — which can take a clinician from sample to result in around four hours — can not only improve patient care but can dramatically reduce costs associated with hospital stay times and antifungal therapies, John McDonough, CEO of T2 Biosystems, told an audience at AMP.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.